论文部分内容阅读
1药源性红细胞疾病1.1药源性再生障碍性贫血(DAA)药物引起再生障碍性贫血的发生率较药源性粒细胞/血小板减少症为低。DAA占全部再生障碍性贫血患者的50%～70%。欧洲和美国DAA的发病率为每年百万分之2到5。我国武汉市对119例再生障碍性贫血发病原因的调查结果,继发性再生障碍性
1 drug-induced erythroid disease 1.1 drug-induced aplastic anemia (DAA) drug-induced aplastic anemia than the incidence of drug-induced neutropenia / thrombocytopenia is low. DAA accounts for 50% to 70% of all patients with aplastic anemia. The incidence of DAA in Europe and the United States is 2-5 parts per million per year. A survey of the causes of 119 cases of aplastic anemia in Wuhan, China, secondary aplastic anemia